People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

2.83USD
17 Apr 2014
Price Change (% chg)

$0.04 (+1.43%)
Prev Close
$2.79
Open
$2.79
Day's High
$2.90
Day's Low
$2.71
Volume
961,150
Avg. Vol
1,816,042
52-wk High
$8.49
52-wk Low
$2.26

Search Stocks

Deshpande, Milind 

Brief Biography

Dr. Milind S. Deshpande, Ph.D., is President, Chief Executive Officer, Director of Achillion Pharmaceuticals Inc. Prior to joining Achillion in September 2001, Dr. Deshpande was Associate Director of Lead Discovery and Early Discovery Chemistry at the Pharmaceutical Research Institute at Bristol-Myers Squibb, a pharmaceutical company, from 1991 to 2001, where he managed the identification of new clinical candidates to treat infectious and neurological diseases. From 1988 to 1991, he held a faculty position at Boston University Medical School. Dr. Deshpande received his Ph.D. in Organic Chemistry from Ohio University, following his undergraduate education in India.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
577,372 -- 929,917 1,507,290

Options Compensation

  Quantity Market Value
Exercisable 485,000 --
Unexercisable -- --
Exercised 15,937 139,342.00
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

1,507,290

Mary Kay Fenton

1,368,890

Gautam Shah

1,526,810

David Apelian

--

Joseph Truitt

1,367,580
As Of 30 Dec 2012
Search Stocks